carbodiimides has been researched along with beta-endorphin in 2 studies
| Studies (carbodiimides) | Trials (carbodiimides) | Recent Studies (post-2010) (carbodiimides) | Studies (beta-endorphin) | Trials (beta-endorphin) | Recent Studies (post-2010) (beta-endorphin) |
|---|---|---|---|---|---|
| 1,534 | 1 | 361 | 6,480 | 409 | 444 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peterson, PK; Shahabi, NA; Sharp, B | 1 |
| Cangro, CB; Neale, JH; Plishka, RJ | 1 |
2 other study(ies) available for carbodiimides and beta-endorphin
| Article | Year |
|---|---|
Beta-endorphin binding to naloxone-insensitive sites on a human mononuclear cell line (U937): effects of cations and guanosine triphosphate.
Topics: Animals; beta-Endorphin; Binding, Competitive; Calcium; Carbodiimides; Cations; Cross-Linking Reagents; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Triphosphate; Humans; Magnesium; Male; Manganese; Molecular Weight; Monocytes; Naloxone; Peptide Fragments; Potassium; Rats; Receptors, Opioid; Sodium; Thionucleotides | 1990 |
Immunohistochemical localization of the pro-opiomelanocortin-gene product, glycylglutamine, in the intermediate pituitary.
Topics: Animals; beta-Endorphin; Carbodiimides; Dipeptides; Endorphins; Fixatives; Fluorescent Antibody Technique; Formaldehyde; Male; Pituitary Gland, Anterior; Polymers; Rats; Rats, Inbred Strains | 1985 |